Features of Swiss-type claims

Managing Intellectual Property


Methods for the diagnosis or treatment of diseases can receive protection in China if presented in a Swiss-type claim. Liantao Li and Tina H. Tai from China Patent Agent (HK) explain this process

Methods for the diagnosis or treatment of diseases are subject matters excluded from patentability in all nations except a few countries such as the US. In most nations and regions such as Europe, Japan and China, however, protection has been made available for new medical or pharmaceutical uses of known compounds/compositions if presented in a Swiss-type claim. This has also been expanded to protect new dosage regimens of known medicaments in Europe.

In response to such an expansion, the Chinese Patent Office (CPO) takes a very conservative position. For example, in its office actions, the CPO typically comments as the following: "A daily dose of 10mg and oral dosing are both an administration feature of a medicament. As a general rule, such a feature of administration per se does not serve as a definition of, or limitation on, a technical solution of any process/use for preparing the medicament".


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @The_IPO: Opening of the #UKChina IP symposium which began today http://t.co/rXGlBMypCo http://t.co/dEEsplCcNJ

Sep 1 2014 09:21 ·  reply ·  retweet ·  favourite
ManagingIP profile

Berne Convention to be extended to Guernsey; enters into force on November 21 2014 http://t.co/laG7rIuaUh @WIPO

Sep 1 2014 09:04 ·  reply ·  retweet ·  favourite
ManagingIP profile

China's National People's Congress announces establishment of IP courts in Beijing, Shanghai and Guangzhou http://t.co/eXcF0ggvSe

Sep 1 2014 04:27 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


September 2014

The surprising rise of the PTAB

Patent owners have been shocked at how popular IPR proceedings at the PTAB have proven. As the USPTO mulls over changes and the Federal Circuit braces itself for a deluge of appeals, Michael Loney reports on how the PTAB is likely to evolve



Most read articles

Supplements